SIC
ARCT icon

SJS Investment Consulting’s Arcturus Therapeutics ARCT Stock Holding History

SJS Investment Consulting’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16K Buy
172
+170
+8,500% +$1.34K ﹤0.01% 1978
2026
Q1 		$16 Buy
+2
New +$15 ﹤0.01% 2386

Other funds holding ARCT

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.98B AUM 29.21% 1-Year Est. Return

SJS Investment Consulting's ARCT Position: Q2 2026 in Review

SJS Investment Consulting increased its Arcturus Therapeutics (ARCT) stake by 8,500% in Q2 2026, buying an estimated $1.34K and bringing the position to 172 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #1978.

SJS Investment Consulting first reported a position in ARCT in Q1 2026 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • SJS Investment Consulting held 172 shares of Arcturus Therapeutics worth $1.16K as of Q2 2026.
  • SJS Investment Consulting bought 170 Arcturus Therapeutics shares in Q2 2026, an estimated $1.34K.
  • Arcturus Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1978 holding.
  • SJS Investment Consulting first reported a position in Arcturus Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 26 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.